reference/25214065

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25214065

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Controlled Clinical Trial\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	647
issn	0022-3476
issueIdentifier	4
pageRange	640-647
publicationName	The Journal of Pediatrics
startingPage	640
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1f038b3945c938d887acb621460444d6
bibliographicCitation	McKinney RE, Pizzo PA, Scott GB, Parks WP, Maha MA, Lehrman SN, Riggs M, Eddy J, Lane BA, Eppes SC, Wilfert CM, Pediatric Zidovudine Phase I Study Group. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. The Journal of Pediatrics. 1990 Apr;116(4):640–7. doi: 10.1016/s0022-3476(05)81619-1.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fac1a5b0a763617af4c02d02bf63cdf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b1d661644a09f0bbb2549dfb9907b2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12f0e2ace12c2f330de437b0814629ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b304378ac81bef35417e5101d56fd0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_792b5409d8d9a975984262d7be56e4f4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4aea622f65af1a96700de3d7b780b47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c8b87835c81a9ef3f28762b06bc252f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bee2a8bc2f157d752055b6260d854aaa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_831909a1fd8ed8da34e29f2d46f81ed0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a387962d48a2fb1d67939440ccab07c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae8eb79558de44938862d18d3ea588f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_238f1e0c2a9fea8f609e06625b1d20cf
date	199004
identifier	https://doi.org/10.1016/s0022-3476%2805%2981619-1 https://pubmed.ncbi.nlm.nih.gov/2181102
isPartOf	https://portal.issn.org/resource/ISSN/0022-3476 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5127
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group
discusses	http://id.nlm.nih.gov/mesh/M0023377
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000386Q000188 http://id.nlm.nih.gov/mesh/D015215Q000627 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D000163Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D012449 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004341 http://id.nlm.nih.gov/mesh/D015215Q000008 http://id.nlm.nih.gov/mesh/D015215Q000009 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D015658Q000276 http://id.nlm.nih.gov/mesh/D007223 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D000386Q000276 http://id.nlm.nih.gov/mesh/D000163Q000097 http://id.nlm.nih.gov/mesh/D004361 http://id.nlm.nih.gov/mesh/D015658Q000097 http://id.nlm.nih.gov/mesh/D000163Q000276 http://id.nlm.nih.gov/mesh/D000386Q000097 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D015337 http://id.nlm.nih.gov/mesh/D002675
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9709 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6780 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e

Total number of triples: 63.